Clinical Trials
3 trialsNCT00325351 2021-04-08
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Bayer
Phase 2 Completed
NCT00246688 2015-12-31
Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer
Bayer
Phase 2 Completed
NCT00751205 2014-10-28
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)
Bayer
Phase 2 Completed